journal article·2023-12-13Open access

Gas Vesicle–Blood Interactions Enhance Ultrasound Imaging Contrast

Bill Ling, Jeong Hoon Ko, Benjamin Stordy, Yuwei Zhang, Tighe F. Didden, Dina Malounda, Margaret B. Swift, Warren C. W. Chan, Mikhail G. Shapiro

Nano Letters· Volume 23· Issue 23

Abstract

High Resolution Image Download MS PowerPoint Slide Gas vesicles (GVs) are genetically encoded, air-filled protein nanostructures of broad interest for biomedical research and clinical applications, acting as imaging and therapeutic agents for ultrasound, magnetic resonance, and optical techniques. However, the biomedical applications of GVs as systemically injectable nanomaterials have been hindered by a lack of understanding of GVs’ interactions with blood components, which can significantly impact in vivo behavior. Here, we investigate the dynamics of GVs in the bloodstream using a combination of ultrasound and optical imaging, surface functionalization, flow cytometry, and mass spectrometry. We find that erythrocytes and serum proteins bind to GVs and shape their acoustic response, circulation time, and immunogenicity. We show that by modifying the GV surface we can alter these interactions and thereby modify GVs’ in vivo performance. These results provide critical insights for the development of GVs as agents for nanomedicine.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Micro and Nano Robotics · Nanopore and Nanochannel Transport Studies · Inhalation and Respiratory Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, United States

Institute of Biomedical Engineering, University of Toronto, Toronto, ON M5S 3G9, Canada

Terrence Donnelly Centre for Cellular & Biomolecular Research, University of Toronto, Toronto, ON M5S 3E1, Canada

Department of Chemistry, University of Toronto, Toronto, ON M5S 3H6, Canada

Division of Engineering and Applied Science, California Institute of Technology, Pasadena, California 91125, United States

Howard Hughes Medical Institute, California Institute of Technology, Pasadena, California 91125, United States

Funding

Canadian Institutes of Health Research · Howard Hughes Medical Institute · National Institute of Biomedical Imaging and Bioengineering · Canada Research Chairs · Donna and Benjamin M. Rosen Bioengineering Center, California Institute of Technology · Kavli Nanoscience Institute, California Institute of Technology · NanoMedicines Innovation Network · Center for Environmental Microbial Interactions, California Institute of Technology

References (59)

Show source-provided references
1. 10.1021/acs.chemrev.5b0014810.1021/acs.chemrev.5b00148 ↗
2. 10.1038/nnano.2012.20710.1038/nnano.2012.207 ↗
3. 10.2217/nnm.15.18810.2217/nnm.15.188 ↗
4. 10.1039/C4CC07644C10.1039/C4CC07644C ↗
5. 10.1021/acsnano.6b0485810.1021/acsnano.6b04858 ↗
6. 10.1038/s41589-022-01093-510.1038/s41589-022-01093-5 ↗
7. 10.1021/acsnano.9b0277410.1021/acsnano.9b02774 ↗
8. 10.1021/nn406018q10.1021/nn406018q ↗
9. 10.2217/nnm.11.1910.2217/nnm.11.19 ↗
10. 10.1016/j.bioactmat.2022.05.00110.1016/j.bioactmat.2022.05.001 ↗
11. 10.1021/acsnano.1c1137410.1021/acsnano.1c11374 ↗
12. 10.4049/jimmunol.180056510.4049/jimmunol.1800565 ↗
13. 10.1146/annurev-chembioeng-060817-08403410.1146/annurev-chembioeng-060817-084034 ↗
14. 10.1128/mr.58.1.94-144.199410.1128/mr.58.1.94-144.1994 ↗
15. 10.1038/nnano.2014.3210.1038/nnano.2014.32 ↗
16. 10.1016/j.neuroimage.2019.11646710.1016/j.neuroimage.2019.116467 ↗
17. 10.1063/5.005080710.1063/5.0050807 ↗
18. 10.1038/s41587-022-01581-y10.1038/s41587-022-01581-y ↗
19. 10.1038/s41592-021-01229-w10.1038/s41592-021-01229-w ↗
20. 10.1002/smll.20220794010.1002/smll.202207940 ↗
21. 10.1016/j.biomaterials.2020.11980310.1016/j.biomaterials.2020.119803 ↗
22. 10.1021/acsnano.6b0336410.1021/acsnano.6b03364 ↗
23. 10.1038/s41589-020-0591-010.1038/s41589-020-0591-0 ↗
24. 10.1021/acsnano.0c0591210.1021/acsnano.0c05912 ↗
25. 10.1038/s41565-021-00971-810.1038/s41565-021-00971-8 ↗
26. 10.1126/sciadv.add918610.1126/sciadv.add9186 ↗
27. 10.1021/acsnano.9b0843210.1021/acsnano.9b08432 ↗
28. 10.1021/acs.nanolett.0c0315910.1021/acs.nanolett.0c03159 ↗
29. 10.1038/s41563-018-0023-710.1038/s41563-018-0023-7 ↗
30. 10.1038/nchem.193410.1038/nchem.1934 ↗
31. 10.1038/nprot.2017.08110.1038/nprot.2017.081 ↗
32. 10.1016/j.jconrel.2008.07.03010.1016/j.jconrel.2008.07.030 ↗
33. 10.1016/j.ultrasmedbio.2019.05.02510.1016/j.ultrasmedbio.2019.05.025 ↗
34. Cobbold R. S. C. · 2007
35. 10.1063/1.497610510.1063/1.4976105 ↗
36. 10.1038/s41551-020-00644-210.1038/s41551-020-00644-2 ↗
37. 10.1039/C8NR07730D10.1039/C8NR07730D ↗
38. 10.1073/pnas.200288011710.1073/pnas.2002880117 ↗
39. 10.1016/j.ultrasmedbio.2019.09.00910.1016/j.ultrasmedbio.2019.09.009 ↗
40. 10.1016/j.bpj.2021.05.00710.1016/j.bpj.2021.05.007 ↗
41. 10.1007/s00281-004-0182-210.1007/s00281-004-0182-2 ↗
42. 10.1021/acsnano.9b0394210.1021/acsnano.9b03942 ↗
43. 10.1016/j.jconrel.2022.09.03110.1016/j.jconrel.2022.09.031 ↗
44. 10.1016/j.nantod.2016.05.00610.1016/j.nantod.2016.05.006 ↗
45. 10.1002/adma.20207031210.1002/adma.202070312 ↗
46. 10.1038/s41592-018-0224-710.1038/s41592-018-0224-7 ↗
47. 10.3389/fimmu.2020.59553510.3389/fimmu.2020.595535 ↗
48. 10.1073/pnas.110663410810.1073/pnas.1106634108 ↗
49. 10.1021/acs.chemmater.2c0116810.1021/acs.chemmater.2c01168 ↗
50. 10.1038/s41467-019-11593-z10.1038/s41467-019-11593-z ↗
51. 10.1038/s41467-018-06979-410.1038/s41467-018-06979-4 ↗
52. 10.1002/adhm.20220056810.1002/adhm.202200568 ↗
53. 10.1038/s41467-020-17033-710.1038/s41467-020-17033-7 ↗
54. 10.1074/mcp.O115.05243110.1074/mcp.O115.052431 ↗
55. 10.3390/vaccines303068610.3390/vaccines3030686 ↗
56. 10.1073/pnas.121635311010.1073/pnas.1216353110 ↗
57. 10.1073/pnas.170174611410.1073/pnas.1701746114 ↗
58. 10.1073/pnas.140986111110.1073/pnas.1409861111 ↗
59. 10.1021/mp100169710.1021/mp1001697 ↗